fomesafen has been researched along with tadalafil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, Y; Izumi, H; Kaiho, Y; Kawamorita, N; Miyazato, M; Nakagawa, H | 1 |
| Magdy, Y; Sedky, AA | 1 |
2 other study(ies) available for fomesafen and tadalafil
| Article | Year |
|---|---|
Effects of phosphodiesterase type 5 inhibitor, tadalafil, on continence reflex in rats.
Topics: Animals; Carbolines; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Muscle Relaxation; Muscle, Smooth; Phosphodiesterase 5 Inhibitors; Rats; Rats, Sprague-Dawley; Reflex; Tadalafil; Treatment Outcome; Urethra; Urethral Diseases; Urinary Incontinence, Stress | 2014 |
Tadalafil versus linaclotide in gastrointestinal dysfunction and depressive behavior in constipation-predominant irritable bowel syndrome.
Topics: Animals; Colon; Constipation; Cyclic GMP; Feces; Gastrointestinal Transit; Hippocampus; Intestine, Large; Irritable Bowel Syndrome; Male; Peptides; Proto-Oncogene Proteins c-fos; Rats, Wistar; Reflex; Swimming; Tadalafil; Water | 2020 |